Central Auditory Functions of Alzheimer's Disease and Its Preclinical Stages: A Systematic Review and Meta-Analysis
- PMID: 35326458
- PMCID: PMC8947537
- DOI: 10.3390/cells11061007
Central Auditory Functions of Alzheimer's Disease and Its Preclinical Stages: A Systematic Review and Meta-Analysis
Abstract
In 2020, 55 million people worldwide were living with dementia, and this number is projected to reach 139 million in 2050. However, approximately 75% of people living with dementia have not received a formal diagnosis. Hence, they do not have access to treatment and care. Without effective treatment in the foreseeable future, it is essential to focus on modifiable risk factors and early intervention. Central auditory processing is impaired in people diagnosed with Alzheimer's disease (AD) and its preclinical stages and may manifest many years before clinical diagnosis. This study systematically reviewed central auditory processing function in AD and its preclinical stages using behavioural central auditory processing tests. Eleven studies met the full inclusion criteria, and seven were included in the meta-analyses. The results revealed that those with mild cognitive impairment perform significantly worse than healthy controls within channel adaptive tests of temporal response (ATTR), time-compressed speech test (TCS), Dichotic Digits Test (DDT), Dichotic Sentence Identification (DSI), Speech in Noise (SPIN), and Synthetic Sentence Identification-Ipsilateral Competing Message (SSI-ICM) central auditory processing tests. In addition, this analysis indicates that participants with AD performed significantly worse than healthy controls in DDT, DSI, and SSI-ICM tasks. Clinical implications are discussed in detail.
Keywords: central-auditory processing; dementia; hearing loss.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
Donepezil for dementia due to Alzheimer's disease.Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3. Cochrane Database Syst Rev. 2018. PMID: 29923184 Free PMC article.
-
Galantamine for Alzheimer's disease.Cochrane Database Syst Rev. 2002;(3):CD001747. doi: 10.1002/14651858.CD001747. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001747. doi: 10.1002/14651858.CD001747.pub2. PMID: 12137632 Updated.
-
Folic acid with or without vitamin B12 for cognition and dementia.Cochrane Database Syst Rev. 2003;(4):CD004514. doi: 10.1002/14651858.CD004514. Cochrane Database Syst Rev. 2003. Update in: Cochrane Database Syst Rev. 2008 Oct 08;(4):CD004514. doi: 10.1002/14651858.CD004514.pub2. PMID: 14584018 Updated.
-
Selegiline for Alzheimer's disease.Cochrane Database Syst Rev. 2003;(1):CD000442. doi: 10.1002/14651858.CD000442. Cochrane Database Syst Rev. 2003. PMID: 12535396
-
Cholinesterase inhibitors for Alzheimer's disease.Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593. Cochrane Database Syst Rev. 2006. PMID: 16437532 Free PMC article.
Cited by
-
An In Silico Study Based on QSAR and Molecular Docking and Molecular Dynamics Simulation for the Discovery of Novel Potent Inhibitor against AChE.Pharmaceuticals (Basel). 2024 Jun 25;17(7):830. doi: 10.3390/ph17070830. Pharmaceuticals (Basel). 2024. PMID: 39065681 Free PMC article.
-
Efficacy of acoustic stimulation techniques on cognitive functions in individuals with Alzheimer's disease-a scoping review.Alzheimers Res Ther. 2024 Aug 1;16(1):174. doi: 10.1186/s13195-024-01544-2. Alzheimers Res Ther. 2024. PMID: 39085956 Free PMC article.
-
Association of Central Auditory Processing Dysfunction With Preclinical Alzheimer's Disease.Otolaryngol Head Neck Surg. 2023 Jul;169(1):112-119. doi: 10.1002/ohn.228. Epub 2023 Jan 29. Otolaryngol Head Neck Surg. 2023. PMID: 36939433 Free PMC article.
-
Development of White Cabbage, Coffee, and Red Onion Extracts as Natural Phosphodiesterase-4B (PDE4B) Inhibitors for Cognitive Dysfunction: In Vitro and In Silico Studies.Adv Pharmacol Pharm Sci. 2024 May 21;2024:1230239. doi: 10.1155/2024/1230239. eCollection 2024. Adv Pharmacol Pharm Sci. 2024. PMID: 38808119 Free PMC article.
-
Hearing impairment is associated with cognitive decline, brain atrophy and tau pathology.EBioMedicine. 2022 Dec;86:104336. doi: 10.1016/j.ebiom.2022.104336. Epub 2022 Nov 7. EBioMedicine. 2022. PMID: 36356475 Free PMC article.
References
-
- Prince M., Wimo A., Guerchet M., Ali G.C., Wu Y.T., Prina M. World Alzheimer Report 2015—The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer’s Disease International; London, UK: 2015.
-
- Purves D., Augustine G., Fitzpatrick D., Hall W., LaMantia A.S., White L. In: Neuroscience. 5th ed. Mooney R., Platt M., editors. Sinauer Associates; Sunderland, MA, USA: 2012. p. 15.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous